ArticleJournal of clinical laboratory analysis2022

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.

Yiming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.